Home
>
National Drug Code (NDC)
>
TRICITRATES
TRICITRATES - 0121-0677-16 - (POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE)
Drug Information of TRICITRATES
| Product NDC: | 0121-0677 |
| Proprietary Name: | TRICITRATES |
| Non Proprietary Name: | POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE |
| Active Ingredient(s): | 334; 550; 500 mg/5mL; mg/5mL; mg/5mL & nbsp; POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TRICITRATES
| Product NDC: | 0121-0677 |
| Labeler Name: | Pharmaceutical Associates, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20050525 |
Package Information of TRICITRATES
| Package NDC: | 0121-0677-16 |
| Package Description: | 473 mL in 1 BOTTLE (0121-0677-16) |
NDC Information of TRICITRATES
| NDC Code | 0121-0677-16 |
| Proprietary Name | TRICITRATES |
| Package Description | 473 mL in 1 BOTTLE (0121-0677-16) |
| Product NDC | 0121-0677 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20050525 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Pharmaceutical Associates, Inc. |
| Substance Name | CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE; SODIUM CITRATE |
| Strength Number | 334; 550; 500 |
| Strength Unit | mg/5mL; mg/5mL; mg/5mL |
| Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
